95 related articles for article (PubMed ID: 5655364)
1. Antimetabolites in the treatment of skin disease.
Alden HS
J Med Assoc Ga; 1968 May; 57(5):224. PubMed ID: 5655364
[No Abstract] [Full Text] [Related]
2. [Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
Schuppli R
Munch Med Wochenschr; 1970 Mar; 112(12):526-30. PubMed ID: 5467837
[No Abstract] [Full Text] [Related]
3. [Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Schuppli R
Minerva Med; 1970 Jul; 61(55):3070-3. PubMed ID: 5427679
[No Abstract] [Full Text] [Related]
4. [Cytostatic drugs in the treatment of neoplasms, with special consideration of neoplasms and some systemic diseases of the skin].
Kostrzewa J
Przegl Dermatol; 1968; 55(2):207-13. PubMed ID: 4878003
[No Abstract] [Full Text] [Related]
5. The action of antimetabolites in the skin: methotrexate for psoriasis.
Weinstein GD
Adv Biol Skin; 1972; 12():287-302. PubMed ID: 4579196
[No Abstract] [Full Text] [Related]
6. Topical tretinoin and 5-fluorouracil in the treatment of linear verrucous epidermal nevus.
Kim JJ; Chang MW; Shwayder T
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):129-32. PubMed ID: 10863239
[TBL] [Abstract][Full Text] [Related]
7. Local chemotherapy of skin.
Cohen M
J Med Assoc Ga; 1979 Jan; 68(1):65-6. PubMed ID: 758368
[No Abstract] [Full Text] [Related]
8. [Immunosuppressive treatment of skin diseases. II. Clinical use of immunosuppressive drugs].
Ruszczak Z
Przegl Dermatol; 1974; 61(4):529-35. PubMed ID: 4603603
[No Abstract] [Full Text] [Related]
9. [Effectiveness and side effects of the treatment of certain dermatoses with methotrexate].
Mashkilleison AL; Glebova LI; Kantsler VS; Kundel' LM; Kliavina VR
Vestn Dermatol Venerol; 1973 Oct; 47(10):69-73. PubMed ID: 4782182
[No Abstract] [Full Text] [Related]
10. Fluorouracil cream (Efudix) in dermatology.
Drug Ther Bull; 1973 Nov; 11(24):94-6. PubMed ID: 4771790
[No Abstract] [Full Text] [Related]
11. Antimetabolites.
Grem JL; Chabner BA; Chu E; Johnson P; Yeh GC; Allegra CJ
Cancer Chemother Biol Response Modif; 1991; 12():1-25. PubMed ID: 1834143
[No Abstract] [Full Text] [Related]
12. Current management using 5-fluorouracil: 1985.
Bennett R; Epstein E; Goette D; Lowe N; Maibach H; Menn H; Tromovitch T
Cutis; 1985 Sep; 36(3):218-22, 227-9, 233-6. PubMed ID: 4053687
[No Abstract] [Full Text] [Related]
13. Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil.
Yuge S; Godoy DA; Melo MC; Sousa DS; Soares CT
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S218-9. PubMed ID: 16631944
[TBL] [Abstract][Full Text] [Related]
14. [Dermatologic aspects of cutaneous pseudocancer].
Nazzaro P
Minerva Med; 1971 Apr; 62(30):1588-91. PubMed ID: 5556772
[No Abstract] [Full Text] [Related]
15. [Possible applications of antivitamins and antimetabolites in therapy].
Frick PG
Bibl Nutr Dieta; 1966; 8():6-16. PubMed ID: 5950495
[No Abstract] [Full Text] [Related]
16. Bowenoid conditions of the skin: treatment with topical 5-fluorouracil.
Jansen GT; Dillaha CJ; Honeycutt WM
South Med J; 1967 Feb; 60(2):185-8. PubMed ID: 6016410
[No Abstract] [Full Text] [Related]
17. Actinic keratoses.
Chia A; Moreno G; Lim A; Shumack S
Aust Fam Physician; 2007 Jul; 36(7):539-43. PubMed ID: 17619671
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma responding to systemic 5-fluorouracil.
Snipes CJ; Sniezek PJ; Walling HW
J Am Acad Dermatol; 2006 Jun; 54(6):1104-6. PubMed ID: 16713484
[No Abstract] [Full Text] [Related]
19. A giant variant of acquired reactive perforating collagenosis associated with hydronephrosis: successful treatment with allopurinol.
Gnanaraj P; Venugopal V; Sangitha C; Rajagopalan V; Pandurangan CN
Int J Dermatol; 2009 Feb; 48(2):204-6. PubMed ID: 19200207
[No Abstract] [Full Text] [Related]
20. Antitumor drugs in diseases of the skin.
McDonald CJ
Conn Med; 1967 Jun; 30(6):416-21. PubMed ID: 6046074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
